News
January 22, 2010 - The California Heart Center, the cardiology group that developed the nation’s largest heart transplant program, has joined the Cedars-Sinai Heart Institute.
January 22, 2010
Feature | Dave Fornell
The debate over healthcare reform has raised many issues as to why costs have risen so much in recent years. During the debates, comments have been made that device manufacturers are a big factor in driving up costs.
January 22, 2010
Technology
Primarily used in the hospital setting, NATRECOR (nesiritide) is used intravenously in patients who have acutely decompensated heart failure with dyspnea (shortness of breath).
January 21, 2010Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology
To support anti-coagulation disease management for patients at risk for stroke and other clotting disorders, the CoagNow offers a home monitoring system. It is designed to manage the potential risks associated with warfarin therapy.
January 21, 2010
News
January 21, 2010 – A new minimally invasive therapy using radiofrequency ablation to short-circuit nerves in the kidney arteries shows promise in treating uncontrolled hypertension. The research was presented this week at the International Symposium on Endovascular Therapy (ISET).
January 21, 2010News
January 21, 2010 - A recent study found generic epoprostenol is a safe and effective therapy alternative to brand name Flolan for patients suffering from pulmonary arterial hypertension (PAH).
January 21, 2010Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
January 21, 2010 – The FDA this week cleared the HeartMate II, a continuous-flow, left ventricular assist device (VAD), as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. The HeartMate II is already FDA-approved for use in patients awaiting further, more complex treatment, such as transplants.
January 21, 2010News
January 21, 2010 – The Federal Patent Court in Munich, Germany upheld the validity of Edward Lifesciences' patent for transcatheter valve technology and dismissed invalidity claims by competitor CoreValve.
January 20, 2010Technology
January 20, 2010 - Advanced breast imaging capabilities added elastography to the list, fused MR/CT image data combined with angiography navigation systems to guide percutaneous oncology, and 3.0 Tesla MR debut at the 2009 Radiological Society of North America (RSNA).
January 20, 2010Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
January 20, 2010 - The IHE 2010 North America Connectathon demonstrated the efficacy of electronic health record system connectivity and interoperable exchange of patient health data with standards-based systems.
January 20, 2010
News
January 20, 2010 - Nearly $1 million of medical equipment and supplies donated by a leading medical manufacturer is being shipped today to Haitia for a team of Caritas Christi clinicians headed to Sacre Coeur Hospital, in Milot, Haiti, north of Port-au-Prince, to use to treat victims of the recent earthquake.
January 20, 2010
Technology
January 20, 2010 - The first FDA-cleared contrast imaging agent for use with a magnetic resonance angiography (MRA) indication to evaluate aortoiliac occlusive disease (AIOD) and suspected peripheral vascular disease enters the U.S. market today.
January 20, 2010Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
January 20, 2010 – The balloon material of the new REEF HP PTA Balloon Catheter was created for use in peripheral high-pressure dilatation procedures, especially to treat hard-to-dilate lesions. The balloon received FDA 510(k) clearance this week.
January 20, 2010Technology
January 20, 2010 – A new contrast-imaging agent for use with magnetic resonance angiography (MRA) is being launched this week in the United States. ABLAVAR (gadofosveset trisodium) is the first MRA injectable imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
January 20, 2010
Technology
January 20, 2010 – The FDA granted 510(k) market clearance for the NUVANT Mobile Cardiac Telemetry (MCT) System for the detection of nonlethal arrhythmias.
January 20, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now